ADMELOG is a fast-acting mealtime insulin for adults with type 1 or type 2 diabetes, and for children (3 years and older) with type 1 diabetes, that:
You may be able to save if you don’t have prescription insurance for your mealtime insulin.
Find out more with ADMELOG FAQs
ADMELOG is available in the ADMELOG SoloStar® pen or a vial, and can be used in a pump.†
See how ADMELOG compares with Humalog, one of the most prescribed mealtime insulins. Any change in your medication should be discussed with your doctor.
For cash-paying patients, the Insulins Valyou Savings Program can help. Learn more.
Eligible patients pay a set price of $99 per month for up to ten 10-mL vials and/or boxes of pens for any one or combination of Sanofi Insulins*
Sanofi insulins included in this program are: ADMELOG® (insulin lispro injection) 100 Units/mL, TOUJEO® (insulin glargine injection) 300 Units/mL, LANTUS® (insulin glargine injection) 100 Units/mL and APIDRA® (insulin glulisine injection) 100 Units/mL.
The Insulins Valyou Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment. The products listed are not therapeutically equivalent and are not interchangeable.
If you and your doctor are considering ADMELOG, having the right information can help.
Click on the questions below to get answers to frequently asked questions.
Side Effects
The most common side effects of ADMELOG include:
These are not all the possible side effects of ADMELOG. It is important to review the labeling that comes with your ADMELOG prescription and speak to your doctor about all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
ADMELOG may cause serious side effects that can lead to death, including:
Get emergency medical help right away if you have:
About ADMELOG
ADMELOG is a fast-acting mealtime insulin that helps to control blood sugar. It is used to attempt to mimic your body’s natural insulin response to blood sugar spikes after meals. It is to be taken within 15 minutes before meals or immediately after.
ADMELOG contains insulin lispro (100 Units/mL), a man-made insulin.
Long-acting insulin (along with diet and exercise) may not be enough to control your blood sugar spikes that happen when you eat. That may be why your doctor has recommended adding ADMELOG.
Unlike long-acting insulin you take once a day, ADMELOG is a fast-acting insulin you take at mealtimes to help you manage blood sugar spikes that happen after you eat. It can help to lower your A1C.
ADMELOG is not a generic for Humalog. However, both ADMELOG and Humalog are:
Be sure to review the possible side effects with your doctor. Your doctor will determine what is right for you.
If your doctor is recommending ADMELOG, you should know that it is a mealtime insulin used to help control blood sugar spikes that occur when you eat.
Your doctor may need to adjust your mealtime insulin dose if you are being switched from NovoLog to ADMELOG.
The cost of mealtime insulin depends on many factors including your health insurance, your dose, or if you are using a pump, pen, or vial.
For cash-paying patients, the Insulins Valyou Savings Program can help.
Patients pay a set price of $99 per month for up to ten 10-mL vials and/or boxes of pens for any one or combination of Sanofi Insulins. Eligibility restrictions apply. Learn more.
The Insulins Valyou Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment.
Using ADMELOG
Do not use ADMELOG if you:
You should ask your doctor which medicines (including over-the-counter and other prescription medicines, vitamins, and herbal supplements) are safe to take if you are using ADMELOG.
Taking certain diabetes pills called thiazolidinediones (TZDs) with ADMELOG may cause heart failure in some people. This can happen even if you have never had heart failure or heart problems before. If you have already had heart failure, it may get worse while you take TZDs with ADMELOG. Your healthcare provider should monitor you closely while you are taking TZDs with ADMELOG.
Tell your healthcare provider if you have any new or worse symptoms of heart failure, including:
Treatment with TZDs and ADMELOG may need to be adjusted or stopped by your healthcare provider if you have new or worse heart failure.
Be sure to tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all of the medicines you take, including:
Before you start using ADMELOG, talk to your healthcare provider about low blood sugar and how to manage it.
You can take ADMELOG using:
Speak to your doctor about what option may be appropriate for you.
You should take ADMELOG within 15 minutes before or immediately after eating a meal.
You can inject ADMELOG in four areas of your body:
Rotate your injection sites with each dose to reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged.
Your dose of ADMELOG may need to change because of:
Before first use
After first use
You should only use your pen for up to 28 days after its first use. Throw away the ADMELOG SoloStar pen you are using after the 28th day, even if it still has insulin left in it.
Be sure to put used needles and syringes in an FDA-cleared disposal container right away after use.
While using ADMELOG, do not:
